G Hasenfuss

Author PubWeight™ 81.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Altered myocardial force-frequency relation in human heart failure. Circulation 1992 3.12
2 Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995 2.27
3 Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J 2000 2.15
4 Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial. Eur Respir J 2006 2.07
5 Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure. Circ Res 1994 2.04
6 Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ Res 1989 1.98
7 Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium. Circ Res 1999 1.87
8 Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation 1995 1.86
9 Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc Res 1999 1.67
10 The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts. Cardiovasc Res 2003 1.59
11 Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium. Cardiovasc Res 2000 1.57
12 Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling. J Clin Invest 1996 1.56
13 Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001 1.45
14 Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol 2000 1.43
15 Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium. Eur Heart J 2002 1.43
16 Long-term clinical experience with the EGM width detection criterion for differentiation of supraventricular and ventricular tachycardia in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2000 1.38
17 Slow breathing reduces sympathoexcitation in COPD. Eur Respir J 2008 1.28
18 Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia 2010 1.23
19 Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. Circ Res 2001 1.21
20 Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. Circulation 2000 1.14
21 Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels. Circulation 1996 1.12
22 Frequency-dependence of myocardial energetics in failing human myocardium as quantified by a new method for the measurement of oxygen consumption in muscle strip preparations. J Mol Cell Cardiol 1998 1.11
23 Preservation of contractile characteristics of human myocardium in multi-day cell culture. J Mol Cell Cardiol 1999 1.09
24 Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure. Circulation 1999 1.05
25 Impaired contractile performance of cultured rabbit ventricular myocytes after adenoviral gene transfer of Na(+)-Ca(2+) exchanger. Circ Res 2000 1.03
26 Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol 1998 1.02
27 Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 1999 0.99
28 The trabecula culture system: a novel technique to study contractile parameters over a multiday time period. Am J Physiol 1998 0.99
29 Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study. Lancet 1999 0.98
30 Over-expression of FK506-binding protein FKBP12.6 alters excitation-contraction coupling in adult rabbit cardiomyocytes. J Physiol 2004 0.97
31 Influence of mild hypothermia on myocardial contractility and circulatory function. Basic Res Cardiol 2001 0.96
32 The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects. Eur J Clin Pharmacol 2006 0.95
33 Pyruvate potentiates inotropic effects of isoproterenol and Ca(2+) in rabbit cardiac muscle preparations. Am J Physiol Heart Circ Physiol 2000 0.91
34 Sarcoplasmic reticulum proteins in heart failure. Ann N Y Acad Sci 1998 0.90
35 Short term effect of continuous positive airway pressure on muscle sympathetic nerve activity in patients with chronic heart failure. Heart 2001 0.89
36 A mechanistic analysis of the force-frequency relation in non-failing and progressively failing human myocardium. Basic Res Cardiol 1998 0.89
37 Load-dependent induction of apoptosis in multicellular myocardial preparations. Am J Physiol Heart Circ Physiol 2002 0.89
38 Transient and sustained impacts of hydroxyl radicals on sarcoplasmic reticulum function: protective effects of nebivolol. Eur J Pharmacol 1999 0.88
39 Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. An in vitro study under physiological experimental conditions. Circulation 1993 0.87
40 Effects of different proton pump inhibitors on cardiac contractility in isolated human failing myocardium. J Cardiovasc Surg (Torino) 2011 0.86
41 Modulation of myothermal economy of isometric force generation by positive inotropic interventions in the guinea pig myocardium. Cardioscience 1990 0.85
42 Influence of endothelin 1 on human atrial myocardium--myocardial function and subcellular pathways. Basic Res Cardiol 1996 0.85
43 Myosin light chain composition in non-failing donor and end-stage failing human ventricular myocardium. Adv Exp Med Biol 2003 0.85
44 Alterations of the force-frequency relationship in the failing human heart depend on the underlying cardiac disease. Basic Res Cardiol 1992 0.84
45 Levosimendan improves diastolic and systolic function in failing human myocardium. Eur J Pharmacol 2000 0.83
46 Pharmacokinetics of hydrochlorothiazide in relation to renal function. Eur J Clin Pharmacol 1983 0.83
47 Calcium pump overexpression and myocardial function. Implications for gene therapy of myocardial failure. Circ Res 1998 0.83
48 Frequency-dependent changes in contribution of SR Ca2+ to Ca2+ transients in failing human myocardium assessed with ryanodine. J Mol Cell Cardiol 1998 0.83
49 Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide. Clin Cardiol 1987 0.81
50 Influence of forskolin on the force-frequency behavior in nonfailing and end-stage failing human myocardium. Basic Res Cardiol 1998 0.81
51 Ca(2+)-dependent and Ca(2+)-independent regulation of contractility in isolated human myocardium. Basic Res Cardiol 1997 0.80
52 Unaltered ryanodine receptor protein levels in ischemic cardiomyopathy. Mol Cell Biochem 1997 0.80
53 Increased basal contractility of cardiomyocytes overexpressing protein kinase C epsilon and blunted positive inotropic response to endothelin-1. Cardiovasc Res 2001 0.80
54 Influence of SR Ca(2+)-ATPase and Na(+)-Ca(2+)-exchanger on the force-frequency relation. Basic Res Cardiol 1998 0.80
55 Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions. Circulation 1995 0.79
56 [A 17-year-old with cardiac mass and pulmonary embolism]. Internist (Berl) 2009 0.79
57 Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease. J Intern Med 2013 0.79
58 Influence of the positive inotropic substance pimobendan (UD-CG 115 BS) on contractile economy of guinea pig papillary muscles. J Cardiovasc Pharmacol 1989 0.79
59 [Differential therapy of heart failure. Which drug for which patient?]. Internist (Berl) 2004 0.78
60 Protective role of nebivolol in hydroxyl radical induced injury. J Cardiovasc Pharmacol 2001 0.78
61 Preservation of myocardial function after adenoviral gene transfer in isolated myocardium. Am J Physiol Heart Circ Physiol 2000 0.78
62 Acute and chronic changes of myocardial energetics in the mammalian and human heart. Basic Res Cardiol 1987 0.78
63 Load-induced cardiomyocyte apoptosis in cultured multicellular myocardial preparations is unaltered in presence of the beta-adrenoceptor antagonist nebivolol. Pharmacology 2008 0.78
64 Repeat determination of left ventricular wall thickness from mass and volume during one cardiac cycle for the calculation of left ventricular wall stress parameters. Clin Cardiol 1990 0.78
65 Myothermal economy of rat myocardium, chronic adaptation versus acute inotropism. Basic Res Cardiol 1986 0.78
66 Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-meth yl-3, 6-dihydro-2H-1,3,4-thiadiazin-2-one on skinned fibres and isolated ventricular strips. Arzneimittelforschung 1996 0.77
67 Impact of beta-adrenoceptor antagonists on myofilament calcium sensitivity of rabbit and human myocardium. J Cardiovasc Pharmacol 2000 0.77
68 The reorganization of the human and rabbit heart in response to haemodynamic overload. Eur Heart J 1992 0.77
69 The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 1991 0.77
70 Cardiac and hemodynamic effects of the sinus node inhibitor tedisamil dihydrochloride in patients with congestive heart failure due to dilated cardiomyopathy. J Cardiovasc Pharmacol 1998 0.76
71 [Efficacy of a cognitive-behavioral program with pharmacological support to achieve smoking cessation]. Dtsch Med Wochenschr 2006 0.76
72 Positive inotropism and myocardial energetics: influence of beta receptor agonist stimulation, phosphodiesterase inhibition, and ouabain. Cardiovasc Res 1994 0.76
73 Functional significance of angiotensin receptors in human myocardium. Significant differences between atrial and ventricular myocardium. Eur Heart J 1994 0.76
74 The functional effect of adenoviral Na+/Ca2+ exchanger overexpression in rabbit myocytes depends on the activity of the Na+/K+-ATPase. Cardiovasc Res 2003 0.76
75 [Pathophysiological basis of heart failure]. Ther Umsch 2000 0.76
76 Cardiac changes in diabetes. Exp Clin Endocrinol Diabetes 1995 0.75
77 Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy. Basic Res Cardiol 1989 0.75
78 Hemodynamics and myocardial oxygen metabolism of pulsus alternans in patients with dilative cardiomyopathy. Clin Cardiol 1987 0.75
79 Assessment of myocardial function by calculation of two energetic parameters from pressure-volume relations and wall thickness in human ventricles. Clin Cardiol 1986 0.75
80 Independent of etozolin elimination of kidney function. Single dose experiments in patients with renal insufficiency. Arzneimittelforschung 1980 0.75
81 Influence of enoximone on mechanics and energetics of right ventricular guinea pig papillary muscles. J Cardiovasc Pharmacol 1989 0.75
82 [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone]. Z Kardiol 1991 0.75
83 Myocardial performance and efficiency as assessed by energetic parameters derived from pressure-volume relations and wall thickness in human ventricles. Z Kardiol 1986 0.75
84 Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy. Am J Cardiol 1988 0.75
85 Myocyte reorganization in hypertrophied and failing hearts. Eur Heart J 1995 0.75
86 Signaling pathways in failing human heart muscle cells. Trends Cardiovasc Med 1997 0.75
87 [Induced platelet aggregation in patients with coronary heart disease as well as trained and untrained control persons]. Z Kardiol 1985 0.75
88 [Immunsuppressive therapy in virus-negative eosinophilic inflammatory cardiomyopathy]. Dtsch Med Wochenschr 2011 0.75
89 Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances. Herz 1991 0.75
90 Cellular and molecular alterations in the failing human heart. Basic Res Cardiol 1992 0.75
91 [Symptoms of primary endocardial fibroelastosis in a young adult]. Dtsch Med Wochenschr 2001 0.75
92 Atheroprotective Krüppel-like factor 4 is downregulated in monocyte subsets of patients with coronary artery disease. Thromb Haemost 2013 0.75
93 The heart in heart failure. Ventricular and myocardial alterations. Eur Heart J 1991 0.75
94 The regulation of calcium cycling in stressed hearts. Basic Res Cardiol 1992 0.75
95 Pharmacokinetics of carteolol in relation to renal function. Eur J Clin Pharmacol 1985 0.75
96 A mechanistic analysis of reduced mechanical performance in human heart failure. Jpn Heart J 2000 0.75
97 [Heart failure - a scientific and clinical challenge]. Dtsch Med Wochenschr 2011 0.75
98 [Heart failure - deliberate diagnosis of various causes or only diagnostic and therapeutic endpoints?]. Herz 2011 0.75
99 Catecholamine metabolism in heart failure patients and healthy control subjects. Arzneimittelforschung 1990 0.75
100 Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure. Basic Res Cardiol 1991 0.75
101 [Successful treatment of fulminant myocarditis with the biventricular MEDOS Assist System (MEDOS HIA-VAD)]. Z Kardiol 1997 0.75
102 Optimization of myocardial function. Basic Res Cardiol 1993 0.75
103 [Optimization of diuretic therapy in heart failure]. Verh Dtsch Ges Inn Med 1985 0.75
104 [Commentary on the 2010 ESC guidelines on device therapy in heart failure ]. Herzschrittmacherther Elektrophysiol 2012 0.75
105 Energetic consequences of positive inotropic interventions in guinea pig papillary muscles. Prog Clin Biol Res 1989 0.75
106 Catecholamine metabolism in patients with congestive heart failure under acute and chronic oral levodopa therapy. Arzneimittelforschung 1990 0.75
107 Contraction frequency dependence of twitch and diastolic tension in human dilated cardiomyopathy (tension-frequency relation in cardiomyopathy). Basic Res Cardiol 1992 0.75
108 Acute effects of nitrates on left ventricular performance and energetics. Z Kardiol 1986 0.75
109 [Acute effects of nitroglycerin on the energetics of the human left ventricular myocardium]. Z Kardiol 1987 0.75
110 Images in cardiology: treatment of tachyarrhythmia induced syncopes by angioplasty of the right coronary artery. Heart 2000 0.75
111 [Acute cor pulmonale in pulmonary embolism. An important prognostic factor and a critical parameter for the choice of a therapeutic strategy]. Internist (Berl) 2004 0.75
112 Pathophysiology and treatment of congestive heart failure. Cardiology 1994 0.75
113 International Gargellen Conference. Circulation 1997 0.75
114 Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy. Am J Cardiol 1987 0.75
115 Myocardial energetics in dilated cardiomyopathy. Clin Cardiol 1990 0.75
116 [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration]. Med Klin (Munich) 1994 0.75
117 [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit]. Z Kardiol 1994 0.75